What should you know about LMP1 immunohistochemistry?

LMP1 is a protein associated with Epstein–Barr virus biology and can be present in some abnormal cells. In immunohistochemistry, laboratory staff apply a marker antibody to prepared tissue. If the target is present, a visible staining pattern may appear under a microscope.

A positive or negative result is interpreted with the tissue appearance, the biopsy diagnosis, symptoms, scans, and sometimes other laboratory tests. Staining can be absent, weak, strong, or limited to particular cells, so the wording of the report matters. LMP1 staining alone does not identify every cause of a tumour or determine treatment by itself.

Usually, no separate procedure is needed for the stain because it is performed on tissue already collected during a biopsy or operation. Ask whether the laboratory had enough suitable tissue and whether additional stains or tests are recommended.

Request a copy of the pathology report and ask the treating specialist to explain the result in the context of the complete diagnosis. Do not interpret a single marker without the rest of the report. If the result is unexpected or treatment decisions are complex, ask whether pathology review or a second opinion would be useful.

LMP1 immunohistochemistry itself does not usually cause symptoms because it is a laboratory analysis. Contact the clinical team about symptoms from the underlying condition or biopsy, such as increasing pain, fever, bleeding, redness, swelling, or discharge at a biopsy site. Seek urgent help for heavy bleeding, severe breathing difficulty, or sudden collapse.

Ask what the LMP1 staining pattern was, which cells stained, how the result fits the biopsy diagnosis, whether other markers are needed, and whether this finding changes staging, treatment, or follow-up.